ETOPOSIDE - LIQ IV 20MG/ML
ETOPOSIDE - LIQ IV 20MG/ML
Discontinued
DIN Number
02227509
Drug Class
Human
Market Date
Jan 28, 1997
Company
HC
bdh inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02227509
AIG Number0114567002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01CB01 ETOPOSIDE
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ETOPOSIDEActive
Strength: 20 MG / ML
Monograph: ETOPOSIDE